CTI BioPharma Corp. Free Cash Flow 2010-2023 | CTIC
CTI BioPharma Corp. free cash flow from 2010 to 2023. Free cash flow can be defined as a measure of financial performance calculated as operating cash flow minus capital expenditures.
| CTI BioPharma Corp. Annual Free Cash Flow |
| 2022 |
-81.19 |
| 2021 |
-84.89 |
| 2020 |
-42.22 |
| 2019 |
-27.82 |
| 2018 |
-39.86 |
| 2017 |
-39.35 |
| 2016 |
-76.82 |
| 2015 |
-95.28 |
| 2014 |
-39.88 |
| 2013 |
-37.36 |
| 2012 |
-65.71 |
| 2011 |
-63.13 |
| 2010 |
-65.05 |
| 2009 |
-88.78 |
| CTI BioPharma Corp. Quarterly Free Cash Flow |
| 2023-03-31 |
-31.10 |
| 2022-12-31 |
-81.19 |
| 2022-09-30 |
-65.68 |
| 2022-06-30 |
-50.22 |
| 2022-03-31 |
-29.98 |
| 2021-12-31 |
-84.89 |
| 2021-09-30 |
-54.87 |
| 2021-06-30 |
-34.37 |
| 2021-03-31 |
-16.78 |
| 2020-12-31 |
-42.22 |
| 2020-09-30 |
-31.39 |
| 2020-06-30 |
-20.01 |
| 2020-03-31 |
-10.44 |
| 2019-12-31 |
-27.82 |
| 2019-09-30 |
-16.34 |
| 2019-06-30 |
-10.74 |
| 2019-03-31 |
-3.46 |
| 2018-12-31 |
-39.86 |
| 2018-09-30 |
-27.21 |
| 2018-06-30 |
-15.14 |
| 2018-03-31 |
-2.46 |
| 2017-12-31 |
-39.35 |
| 2017-09-30 |
-28.79 |
| 2017-06-30 |
-8.04 |
| 2017-03-31 |
-8.70 |
| 2016-12-31 |
-76.82 |
| 2016-09-30 |
-62.25 |
| 2016-06-30 |
-48.99 |
| 2016-03-31 |
-23.09 |
| 2015-12-31 |
-95.28 |
| 2015-09-30 |
-73.15 |
| 2015-06-30 |
-48.95 |
| 2015-03-31 |
-24.03 |
| 2014-12-31 |
-39.88 |
| 2014-09-30 |
-43.66 |
| 2014-06-30 |
-38.47 |
| 2014-03-31 |
-20.82 |
| 2013-12-31 |
-37.36 |
| 2013-09-30 |
-47.44 |
| 2013-06-30 |
-31.90 |
| 2013-03-31 |
-16.32 |
| 2012-12-31 |
-65.71 |
| 2012-09-30 |
-47.72 |
| 2012-06-30 |
-34.23 |
| 2012-03-31 |
-19.21 |
| 2011-12-31 |
-63.13 |
| 2011-09-30 |
-56.74 |
| 2011-06-30 |
-39.83 |
| 2011-03-31 |
-24.93 |
| 2010-12-31 |
-65.05 |
| 2010-09-30 |
-51.51 |
| 2010-06-30 |
-40.32 |
| 2010-03-31 |
-24.30 |
| 2009-12-31 |
-88.78 |
| 2009-09-30 |
-70.99 |
| 2009-06-30 |
-50.98 |
| 2009-03-31 |
-19.22 |
